Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Mathematical Modelling of Immune Parameters in the Evolution of Severe Dengue.

Premaratne MK, Perera SS, Malavige GN, Jayasinghe S.

Comput Math Methods Med. 2017;2017:2187390. doi: 10.1155/2017/2187390. Epub 2017 Feb 15.

2.

Mathematical modelling and a systems science approach to describe the role of cytokines in the evolution of severe dengue.

Jayasundara SD, Perera SS, Malavige GN, Jayasinghe S.

BMC Syst Biol. 2017 Mar 11;11(1):34. doi: 10.1186/s12918-017-0415-3.

3.

Maintenance of demographic and hematological profiles in a long-lasting dengue fever outbreak: implications for management.

Dos Santos Carmo AM, Suzuki RB, Riquena MM, Eterovic A, Sperança MA.

Infect Dis Poverty. 2016 Sep 5;5(1):84. doi: 10.1186/s40249-016-0177-y.

4.

The 2011 dengue haemorrhagic fever outbreak in Lahore - an account of clinical parameters and pattern of haemorrhagic complications.

Ahmed S, Mohammad WW, Hamid F, Akhter A, Afzal RK, Mahmood A.

J Coll Physicians Surg Pak. 2013 Jul;23(7):463-7. doi: 07.2013/JCPSP.463467.

PMID:
23823947
5.

Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.

Lau L, Green AM, Balmaseda A, Harris E.

J Clin Virol. 2015 Aug;69:63-7. doi: 10.1016/j.jcv.2015.06.003. Epub 2015 Jun 5.

6.

Total immunoglobulin E levels and dengue infection on San Andrés Island, Colombia.

Míguez-Burbano MJ, Jaramillo CA, Palmer CJ, Shor-Posner G, Velásquez LS, Lai H, Baum MK.

Clin Diagn Lab Immunol. 1999 Jul;6(4):624-6.

7.

Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection.

Chuang YC, Wang SY, Lin YS, Chen HR, Yeh TM.

J Biomed Sci. 2013 Jun 27;20:42. doi: 10.1186/1423-0127-20-42. Review.

8.

Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever.

Bachal R, Alagarasu K, Singh A, Salunke A, Shah P, Cecilia D.

Arch Virol. 2015 Oct;160(10):2435-43. doi: 10.1007/s00705-015-2519-7. Epub 2015 Jul 15.

PMID:
26175069
9.

Dengue hemorrhagic fever: comparison of patients with primary and secondary infections.

Khurram M, Qayyum W, Hassan SJ, Mumtaz S, Bushra HT, Umar M.

J Infect Public Health. 2014 Nov-Dec;7(6):489-95. doi: 10.1016/j.jiph.2014.05.005. Epub 2014 Jul 4.

10.

Autoimmune pathogenesis in dengue virus infection.

Lin CF, Wan SW, Cheng HJ, Lei HY, Lin YS.

Viral Immunol. 2006 Summer;19(2):127-32. Review.

PMID:
16817755
11.
12.

Interleukin-10 as a Marker of Disease Progression in Dengue Hemorrhagic Fever.

Tauseef A, Umar N, Sabir S, Akmal A, Sajjad S, Zulfiqar S.

J Coll Physicians Surg Pak. 2016 Mar;26(3):187-90. doi: 03.2016/JCPSP.187190.

PMID:
26975948
13.

Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease.

Yong YK, Tan HY, Jen SH, Shankar EM, Natkunam SK, Sathar J, Manikam R, Sekaran SD.

J Transl Med. 2017 May 31;15(1):121. doi: 10.1186/s12967-017-1226-4.

14.

Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.

Guilarde AO, Turchi MD, Siqueira JB Jr, Feres VC, Rocha B, Levi JE, Souza VA, Boas LS, Pannuti CS, Martelli CM.

J Infect Dis. 2008 Mar 15;197(6):817-24. doi: 10.1086/528805.

PMID:
18269315
15.

A strong interferon response correlates with a milder dengue clinical condition.

De La Cruz Hernández SI, Puerta-Guardo H, Flores-Aguilar H, González-Mateos S, López-Martinez I, Ortiz-Navarrete V, Ludert JE, Del Angel RM.

J Clin Virol. 2014 Jul;60(3):196-9. doi: 10.1016/j.jcv.2014.04.002. Epub 2014 Apr 13.

PMID:
24793964
16.

Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity.

Duong V, Ly S, Lorn Try P, Tuiskunen A, Ong S, Chroeung N, Lundkvist A, Leparc-Goffart I, Deubel V, Vong S, Buchy P.

PLoS Negl Trop Dis. 2011 Jul;5(7):e1244. doi: 10.1371/journal.pntd.0001244. Epub 2011 Jul 19.

17.

Characterization of atypical lymphocytes and immunophenotypes of lymphocytes in patients with dengue virus infection.

Jampangern W, Vongthoung K, Jittmittraphap A, Worapongpaiboon S, Limkittikul K, Chuansumrit A, Tarunotai U, Chongsa-nguan M.

Asian Pac J Allergy Immunol. 2007 Mar;25(1):27-36.

18.

A three-component biomarker panel for prediction of dengue hemorrhagic fever.

Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, Forshey BM, Halsey ES, Comach G, Sierra G, Blair PJ, Rocha C, Morrison AC, Scott TW, Bazan I, Kochel TJ; Venezuelan Dengue Fever Working Group.

Am J Trop Med Hyg. 2012 Feb;86(2):341-8. doi: 10.4269/ajtmh.2012.11-0469.

19.

Dengue specific immunoglobulins M, A, and E in primary and secondary dengue 4 infected Salvadorian children.

Vazquez S, Lozano C, Perez AB, Castellanos Y, Ruiz D, Calzada N, Guzmán MG.

J Med Virol. 2014 Sep;86(9):1576-83. doi: 10.1002/jmv.23833. Epub 2013 Nov 19.

PMID:
24615872
20.

Evaluation of host and viral factors associated with severe dengue based on the 2009 WHO classification.

Pozo-Aguilar JO, Monroy-Martínez V, Díaz D, Barrios-Palacios J, Ramos C, Ulloa-García A, García-Pillado J, Ruiz-Ordaz BH.

Parasit Vectors. 2014 Dec 11;7:590. doi: 10.1186/s13071-014-0590-7.

Supplemental Content

Support Center